Birdwatch Note
2023-06-14 06:49:57 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Les études démontrent l'inefficacité de l'usage de l'hydroxychloroquine contre le Covid-19, défendu par Didier Raoult. Il ne comporte aucun bénéfice dans le traitement de la maladie et ne permet pas de sauver des vies. De plus il expose les patients à des risques cardiaques. https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19
Written by A4EF4C27EBBADDB6B1E610790004725BB75B06D5D13C8D186A3E71C388F4F430
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1668680143915606016
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1668873390864605184
- noteId - 1668873390864605184
- participantId -
- noteAuthorParticipantId - A4EF4C27EBBADDB6B1E610790004725BB75B06D5D13C8D186A3E71C388F4F430 Participant Details
- createdAtMillis - 1686725397206
- tweetId - 1668680143915606016
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Les études démontrent l'inefficacité de l'usage de l'hydroxychloroquine contre le Covid-19, défendu par Didier Raoult. Il ne comporte aucun bénéfice dans le traitement de la maladie et ne permet pas de sauver des vies. De plus il expose les patients à des risques cardiaques. https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-06-14 06:49:57 UTC (1686725397206) |
2023-06-14 14:10:26 UTC (1686751826014) |
CURRENTLY_RATED_HELPFUL | 2023-06-15 02:12:24 UTC (1686795144909) |
CURRENTLY_RATED_HELPFUL | 2023-06-14 14:10:26 UTC (1686751826014) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-06-14 15:33:06 -0500 | Rating Details | |
| 2023-06-14 14:24:42 -0500 | Rating Details | |
| 2023-06-14 14:03:47 -0500 | Rating Details | |
| 2023-06-14 13:40:09 -0500 | Rating Details | |
| 2023-06-14 13:28:29 -0500 | Rating Details | |
| 2023-06-14 13:07:17 -0500 | Rating Details | |
| 2023-06-14 13:03:32 -0500 | Rating Details | |
| 2023-06-14 12:25:58 -0500 | Rating Details | |
| 2023-06-14 11:45:02 -0500 | Rating Details | |
| 2023-06-14 10:14:46 -0500 | Rating Details | |
| 2023-06-14 10:14:13 -0500 | Rating Details | |
| 2023-06-14 10:13:34 -0500 | Rating Details | |
| 2023-06-14 10:06:52 -0500 | Rating Details | |
| 2023-06-14 10:04:13 -0500 | Rating Details | |
| 2023-06-14 10:00:22 -0500 | Rating Details | |
| 2023-06-14 09:56:15 -0500 | Rating Details | |
| 2023-06-14 09:55:39 -0500 | Rating Details | |
| 2023-06-14 09:51:16 -0500 | Rating Details | |
| 2023-06-14 09:50:59 -0500 | Rating Details | |
| 2023-06-14 09:48:37 -0500 | Rating Details | |
| 2023-06-14 09:48:35 -0500 | Rating Details | |
| 2023-06-14 09:44:55 -0500 | Rating Details | |
| 2023-06-14 09:44:13 -0500 | Rating Details | |
| 2023-06-14 09:43:58 -0500 | Rating Details | |
| 2023-06-14 09:42:23 -0500 | Rating Details | |
| 2023-06-14 09:41:58 -0500 | Rating Details | |
| 2023-06-14 09:39:19 -0500 | Rating Details | |
| 2023-06-14 09:38:31 -0500 | Rating Details | |
| 2023-06-14 09:37:17 -0500 | Rating Details | |
| 2023-06-14 09:37:12 -0500 | Rating Details | |
| 2023-06-14 09:36:41 -0500 | Rating Details | |
| 2023-06-14 09:36:27 -0500 | Rating Details | |
| 2023-06-14 09:35:45 -0500 | Rating Details | |
| 2023-06-14 09:33:32 -0500 | Rating Details | |
| 2023-06-14 09:27:22 -0500 | Rating Details | |
| 2023-06-14 09:06:49 -0500 | Rating Details | |
| 2023-06-14 09:03:25 -0500 | Rating Details | |
| 2023-06-14 08:54:16 -0500 | Rating Details | |
| 2023-06-14 08:52:33 -0500 | Rating Details | |
| 2023-06-14 08:48:30 -0500 | Rating Details | |
| 2023-06-14 08:39:07 -0500 | Rating Details | |
| 2023-06-14 08:38:01 -0500 | Rating Details | |
| 2023-06-14 08:37:39 -0500 | Rating Details | |
| 2023-06-14 08:34:57 -0500 | Rating Details | |
| 2023-06-14 08:23:52 -0500 | Rating Details | |
| 2023-06-14 08:19:14 -0500 | Rating Details | |
| 2023-06-14 08:17:27 -0500 | Rating Details | |
| 2023-06-14 08:16:45 -0500 | Rating Details | |
| 2023-06-14 08:11:38 -0500 | Rating Details | |
| 2023-06-14 08:07:10 -0500 | Rating Details | |
| 2023-06-14 07:54:24 -0500 | Rating Details | |
| 2023-06-14 07:48:38 -0500 | Rating Details | |
| 2023-06-14 07:46:20 -0500 | Rating Details | |
| 2023-06-14 07:46:07 -0500 | Rating Details | |
| 2023-06-14 07:39:20 -0500 | Rating Details | |
| 2023-06-14 07:39:04 -0500 | Rating Details | |
| 2023-06-14 07:38:15 -0500 | Rating Details | |
| 2023-06-14 07:29:53 -0500 | Rating Details | |
| 2023-06-14 07:29:32 -0500 | Rating Details | |
| 2023-06-14 07:28:15 -0500 | Rating Details | |
| 2023-06-14 07:28:05 -0500 | Rating Details | |
| 2023-06-14 07:19:54 -0500 | Rating Details | |
| 2023-06-14 07:16:05 -0500 | Rating Details | |
| 2023-06-14 07:14:04 -0500 | Rating Details | |
| 2023-06-14 07:10:15 -0500 | Rating Details | |
| 2023-06-14 07:08:15 -0500 | Rating Details | |
| 2023-06-14 07:05:50 -0500 | Rating Details | |
| 2023-06-14 07:02:22 -0500 | Rating Details | |
| 2023-06-14 07:01:54 -0500 | Rating Details | |
| 2023-06-14 07:01:31 -0500 | Rating Details | |
| 2023-06-14 07:00:23 -0500 | Rating Details | |
| 2023-06-14 06:54:33 -0500 | Rating Details | |
| 2023-06-14 06:51:56 -0500 | Rating Details | |
| 2023-06-14 06:48:04 -0500 | Rating Details | |
| 2023-06-14 06:44:01 -0500 | Rating Details | |
| 2023-06-14 06:43:32 -0500 | Rating Details | |
| 2023-06-14 06:43:11 -0500 | Rating Details | |
| 2023-06-14 06:40:51 -0500 | Rating Details | |
| 2023-06-14 06:39:24 -0500 | Rating Details | |
| 2023-06-14 06:37:47 -0500 | Rating Details | |
| 2023-06-14 06:35:18 -0500 | Rating Details | |
| 2023-06-14 06:33:40 -0500 | Rating Details | |
| 2023-06-14 06:31:47 -0500 | Rating Details | |
| 2023-06-14 06:30:38 -0500 | Rating Details | |
| 2023-06-14 06:28:30 -0500 | Rating Details | |
| 2023-06-14 06:28:29 -0500 | Rating Details | |
| 2023-06-14 06:26:45 -0500 | Rating Details | |
| 2023-06-14 06:23:58 -0500 | Rating Details | |
| 2023-06-14 06:21:32 -0500 | Rating Details | |
| 2023-06-14 06:18:56 -0500 | Rating Details | |
| 2023-06-14 06:17:07 -0500 | Rating Details | |
| 2023-06-14 06:17:06 -0500 | Rating Details | |
| 2023-06-14 06:17:03 -0500 | Rating Details | |
| 2023-06-14 06:15:12 -0500 | Rating Details | |
| 2023-06-14 06:11:54 -0500 | Rating Details | |
| 2023-06-14 06:04:04 -0500 | Rating Details | |
| 2023-06-14 06:03:14 -0500 | Rating Details | |
| 2023-06-14 06:01:51 -0500 | Rating Details | |
| 2023-06-14 04:14:40 -0500 | Rating Details | |
| 2023-06-14 03:47:44 -0500 | Rating Details | |
| 2023-06-14 02:45:07 -0500 | Rating Details | |
| 2023-06-14 02:43:12 -0500 | Rating Details | |
| 2023-06-14 02:15:12 -0500 | Rating Details | |
| 2023-06-14 02:04:40 -0500 | Rating Details | |
| 2023-06-14 01:55:32 -0500 | Rating Details | |
| 2023-06-15 11:52:55 -0500 | Rating Details | |
| 2023-06-15 01:11:01 -0500 | Rating Details | |
| 2023-06-15 00:35:49 -0500 | Rating Details | |
| 2023-06-14 17:53:19 -0500 | Rating Details | |
| 2023-06-14 12:24:57 -0500 | Rating Details | |
| 2023-09-12 18:01:35 -0500 | Rating Details |